Herpes simplex virus (HSV) is a recognized cause of gastrointestinal infection in immunodeficient patients. Although a few cases of HSV gastritis and colitis in immunocompromised patients have been reported, there are no reports of HSV duodenitis in patients with Crohn's disease (CD). A 74-year-old female was admitted with general weakness and refractory epigastric pain. She had been diagnosed with CD three years ago. Esophagogastroduodenoscopy (EGD) revealed diffuse edematous and whitish mucosa with multiple erosions in the duodenum. Considering the possibility of viral co-infection, cytomegalovirus (CMV) immunohistochemical staining, PCR, and cultures of duodenal biopsies were performed, all of which were negative with the exception of the isolation of HSV in culture. After administration of intravenous acyclovir for 1 week, follow-up EGD showed almost complete resolution of the lesions and the patient's symptoms improved. In CD patients with refractory gastrointestinal symptoms, HSV, as well as CMV, should be considered as a possible cause of infection, so that the diagnosis of viral infection is not delayed and the appropriate antiviral treatment can be initiated. (Korean J Gastroenterol 2013;62:292-295) 
INTRODUCTION
With the increasing use of immunosuppressive and biological therapies, the incidence of opportunistic infections in patients with inflammatory bowel disease (IBD) is increasing. 1 Cytomegalovirus (CMV) and Epstein-Barr virus are the most common opportunistic viral pathogens in those with IBD. 2 In addition, varicella-zoster virus and human herpes virus 6 have been reported in IBD patients. 
CASE REPORT
A 74-year-old female was admitted with complaints of general weakness and refractory epigastric pain for 3 months despite continuous proton pump inhibitor treatment. She had been diagnosed with CD involving the ileum through the ileocecal (IC) valve outside the hospital 3 years prior. She had been taking an oral steroid (10 mg/day) intermittently over the past 3 years, depending on her symptoms. One year ago, she started taking additional azathioprine (50 mg/day) because her symptoms had become aggravated. However, these medications were discontinued due to gastrointestinal side effects including nausea and vomiting. Since then, she has been taking low-dose oral prednisolone (2.5 mg/day) and mesalazine (3 g/day). She has also been taking aspirin for coronary artery disease and a β-blocker for hypertension.
EGD conducted 6 months prior to admission showed minimal changes in the reflux esophagitis and multiple gastric erosions, and no specific findings were observed in the duodenum. Upon admission to our hospital, she had no other symptoms such as diarrhea, hematochezia or melena. Vital signs were stable (blood pressure 130/80 mmHg, heart rate 80 beats/min, and body temperature 36. and whitish mucosa were found in the duodenum (Fig. 1A) .
We conducted duodenal biopsies. Microscopically, there were acute and chronic nonspecific inflammation without a transmural pattern of inflammation, crypts containing infiltrating mononuclear cells, and non-caseating granulomas (Fig. 2) . Due to suspicions of a viral coinfection, we conducted CMV immunohistochemical staining, PCR analysis, and cultures of the duodenal biopsy specimen, all of which were negative, with the exception of the isolation of HSV in the culture.
Intravenous acyclovir (5 mg/kg, every 8 hour) was administered for 1 week. The epigastric discomfort improved about 3 days after the acyclovir treatment was started and
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DISCUSSION
HSV infection is classified as primary or recurrent. Primary HSV infection causes an asymptomatic or mild oral labial (usually HSV-1) or genital (usually HSV-2) infection in immunocompetent patients. 3 Recurrent herpes infections may occur in immune-impaired patients, such as those with the human immunodeficiency virus or cancer, in whom infection may be more severe and more frequent. 4 Latent HSV in the vagal ganglia might be activated as a consequence of either the general condition of the host or as a local event. 5 In immunocompromised, burned, or malnourished patients, HSV occasionally involves the visceral organs, such as the small and large intestines. 6 HSV infection can affect patients with CD undergoing immunomodulatory therapy. In the current case, we believe that the duodenal herpes was a recurrent infection.
Because gastrointestinal involvement of HSV is uncommon, the European Crohn's and Colitis Organization does not recommend screening for latent HSV infection in IBD patients, even before the commencement of immunomodulatory therapy. 7 Furthermore, duodenal involvement in HSV has not been reported, and this is to our knowledge the first report of HSV duodenitis in a patient with CD.
In this patient, the endoscopic findings showed nonspecific inflammation, with discrete, coalescent ulcerations in the esophagus and multiple small, raised, ulcerated plaques or linear, superficial ulceration in the stomach; the findings differed from those typical of HSV infection in the upper gastrointestinal tract. 8, 9 Although we considered CMV infection to be a more likely diagnosis, we performed duodenal 13 The application of in situ hybridization or PCR assays in addition to immunohistochemical techniques to investigate duodenal specimens might improve the diagnostic sensitivity for HSV duodenitis. 3 Although HSV PCR was performed, we cultured the duodenal biopsy specimens and consequently confirmed the presence of HSV duodenitis.
In the setting of mucocutaneous HSV infection, intravenous acyclovir (5 mg/kg, every 8 hour for 7 to 14 days) is effective against symptomatic HSV infection. 4 In patients who are immunocompromised, experts recommend antiviral therapy for 14 to 21 days. 14 In this case, antiviral therapy was discontinued after about 7 days because the patient complained of severe headache while on the medication, and her symptoms and endoscopic findings had improved.
In conclusion, if gastroduodenal lesions that do not respond to treatment are found in CD, then HSV should be considered as a possible causative pathogen, so that the diagnosis is not delayed and the appropriate antiviral treatment can be initiated promptly.
